BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 5, 2003
View Archived Issues
Pfizer presents new CCR1 antagonists for arthritis and other disorders
Read More
Novel factor Xa inhibitors developed at BMS
Read More
Vertex describes new protein kinase inhibitors
Read More
Cytovia scientists design caspase activators and apoptosis inducers
Read More
Arizona State U. researchers design new combretastatin A3 prodrugs
Read More
Pyrimidine-based tyrosine kinase inhibitors covered by Merck patent
Read More
Dual-target antibacterial compounds discovered at Microbiotix
Read More
Novel antibacterial isoxazolones prepared and tested by Pharmacia scientists
Read More
AnorMED files orphan drug application for AMD-3100
Read More
Second phase III study planned for LAX-101
Read More
Antex files initial IND for Tracvax
Read More
Applied Genetic Technologies' A1AD treatment granted orphan drug status
Read More
Positive phase III results obtained for Metformin GR in type 2 diabetes
Read More
NP-1 demonstrates efficacy in phase II neuropathy trial
Read More
Enrollment completed in phase III trial of MBI-226
Read More
Northfield submits response to FDA regarding PolyHeme phase III trial
Read More
Goal attainment in donepezil-treated AD patients and correlation with standard measures of efficacy
Read More
New phase I trial for VNP-40101M in solid tumors
Read More
Improvement of hyperandrogenic alopecia in women after 1-year treatment with flutamide
Read More
Grant supports study of HE-2200 for treatment of traumatic shock
Read More
AOD-9604 progresses in clinic
Read More
SBIR grant supports MitoKor efforts in glaucoma
Read More
2C3 antibody inhibits tumor growth by 75%
Read More
Preclinical profile of SU-11248 and PK/PD data published
Read More
FDA aims to improve and streamline the drug development and review process
Read More
Safety of DEAE-rebeccamycin in patients with advanced hepatobiliary cancer
Read More
Cialis now available for prescription in several markets
Read More
Abbott Japan begins operations
Read More